SCHEMBL8285263

SCHEMBL8285263

O=C(CCc1cc(C(F)(F)F)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1)Nc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.56
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPT P10636 6/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
MIF P14174 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
TP53 P04637 4/20 0.36
RXFP1 Q9HBX9 1/20 0.36
HTT P42858 1/20 0.36
MAOB P27338 1/20 0.34
HDAC3 O15379 1/20 0.34
NCOR1 O75376 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8362903 0.92 PDE11A (0.56) PDE11AMEN1KMT2AMAPTPOLB
SCHEMBL8285254 0.92 PDE11A (0.59) PDE11AMEN1KMT2AMAPTPOLB
SCHEMBL8285257 0.90 PDE11A (0.57) PDE11AMEN1KMT2AMAPTPOLB
SCHEMBL8285280 0.88 PDE11A (0.56) PDE11AMEN1KMT2AMAPTGAA
SCHEMBL8285258 0.88 PDE11A (0.55) PDE11AMEN1KMT2AMAPTPOLB
SCHEMBL8286114 0.87 PDE11A (0.53) PDE11AMEN1KMT2AMAPTPOLB
SCHEMBL8285152 0.85 PDE11A (0.56) PDE11AMEN1KMT2AMAPTPOLB
SCHEMBL8285266 0.85 PDE11A (0.57) PDE11AMEN1KMT2AMAPTGAA
SCHEMBL8285287 0.84 PDE11A (0.63) PDE11AMEN1KMT2AMAPTPOLB
SCHEMBL8287836 0.83 PDE11A (0.56) PDE11AMAPTPOLBTP53RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed